Abiopharma

Bioxytran’s Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment

New Form SC TO-T/A - CARGO Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001999371-25-010761 Size: 42 KB

New Form 10-Q - Processa Pharmaceuticals, Inc. Filed: 2025-08-07 AccNo: 0001493152-25-011685 Size: 4 MB

New Form 10-Q - CorMedix Inc. Filed: 2025-08-07 AccNo: 0001213900-25-072843 Size: 6 MB

New Form SCHEDULE 13G - China SXT Pharmaceuticals, Inc. Filed: 2025-08-07 AccNo: 0001213900-25-072841 Size: 6 KB

New Form 4 - AtriCure, Inc. Filed: 2025-08-07 AccNo: 0001862458-25-000003 Size: 4 KB

New Form SCHEDULE 13G - China SXT Pharmaceuticals, Inc. Filed: 2025-08-07 AccNo: 0001213900-25-072838 Size: 6 KB

New Form S-8 - Akebia Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001193125-25-175015 Size: 278 KB

PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights

New Form 4 - Enhabit, Inc. Filed: 2025-08-07 AccNo: 0001803737-25-000153 Size: 4 KB

New Form 10-Q - Disc Medicine, Inc. Filed: 2025-08-07 AccNo: 0001816736-25-000007 Size: 9 MB

New Form 4 - Enhabit, Inc. Filed: 2025-08-07 AccNo: 0001803737-25-000152 Size: 4 KB

New Form SCHEDULE 13G - China SXT Pharmaceuticals, Inc. Filed: 2025-08-07 AccNo: 0001213900-25-072835 Size: 6 KB

New Form 8-K - Disc Medicine, Inc. Filed: 2025-08-07 AccNo: 0001816736-25-000006 Size: 509 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 4 - Enhabit, Inc. Filed: 2025-08-07 AccNo: 0001803737-25-000151 Size: 5 KB